TableĀ 1.
Author | Year | Location | Sample size | Participant age | Questionnaire used | Treatment phase |
---|---|---|---|---|---|---|
Hodgkinson | 2006 | Australia | 54 | 58.2 | HADS | Post-treatment |
Wenzel | 2002 | USA | 49 | 55.9 | CES-D | Post-treatment |
Liavaag | 2007 | Norway | 189 | 59.3 | HADS | Post-treatment |
Hipkins | 2004 | UK | 63 | 58.2 | HADS | Pretreatment and post-treatment |
Bisseling | 2009 | Australia | 62 | 36.5 | HADS | Post-treatment |
Norton | 2004 | USA | 143 | 55.0 | BDI | On-treatment |
Parker | 2006 | USA | 126 | 58.7 | CES-D | On-treatment |
Goncalves | 2008 | UK | 121 | 61.1 | HADS | On-treatment and post-treatment |
Costanzo | 2005 | USA | 61 | 60.1 | CES-D | Pretreatment |
Price | 2010 | Australia | 798 | 60.0 | HADS | Pretreatment, treatment |
Sukegawa | 2008 | Japan | 27 | 50.1 | STAI | On-treatment |
Liavaag | 2007 | Norway | 189 | 57.8 | HADS | On-treatment |
Price | 2009 | Australia | 613 | 60.5 | HADS | Pretreatment and on-treatment |
Goncalves | 2010 | UK | 21 | 58.8 | HADS | Pretreatment and post-treatment |
Slovacek | 2009 | Czech Republic | 30 | 62.1 | SDS | On-treatment |
Lutgendorf | 2009 | USA | 19 | 61.0 | CES-D and BDI | Pretreatment |
Schulman-Green | 2008 | USA | 84 | 60.8 | STAI and CES-D | Pretreatment |
Stafford | 2010 | Australia | 71 | 58.5 | HADS | On-treatment and post-treatment |
Urbaniec | 2011 | Australia | 21 | 56.7 | BDI and STAI | Post-treatment |
Clevenger | 2013 | USA | 301 | 59.4 | CES-D | Pretreatment, on-treatment and post-treatment |
Holzner | 2003 | Austria | 98 | 57.4 | HADS | Post-treatment |
Lutgendorf | 2008 | USA | 56 | 63.5 | CES-D | Pretreatment |
Lutgendorf | 2008 | USA | 86 | 55.6 | CES-D | Pretreatment |
Meraner | 2012 | Austria | 55 | 52.8 | HADS | Pretreatment, on-treatment and post-treatment |
BDI, Beck Depression Inventory; CES-D, Centre for Epidemiologic Studies Depression Scale; HADS, Hospital Anxiety and Depression Scale; SDS, Self-Rating Depression Scale; STAI, State-Trait Anxiety Scale.